In the modern world of information technology, the use of drug information properties is appropriate. This provides an entirely new approach to using well-known, officially approved drugs to treat diseases caused by various pathogens. We discuss using "a device to transfer information from a drug to the human body."
Why was there a need to develop these technologies?
First of all, this approach concerns the therapy of chronic pathology where one or another pathogen takes part in the pathogenesis of the disease - a virus, bacteria, fungi, etc. These include all known viral infections - chronic viral hepatitis, chronic herpes infection; bacterial infection that can cause chronic damage to any internal organ, from chronic tonsillitis to chronic sepsis, and a fungal infection, which in the human body most often presents as the manifestation of secondary immunodeficiency, the marker of which is the clinical picture of systemic candidiasis caused by Candida spp.
The presented photos (on the poster presentation) demonsrates the results of therapy of a patient with a chronic septic condition who, for more than 20 years, underwent monthly surgery to evacuate the purulent contents of numerous phlegmons arising in various tissues of her body (the result of an unsuccessful appendectomy at the age of five). Five different pathogens were isolated from the pus of our patient, four of which represented the so-called hospital-acquired infections: Staphylococcus aureus, Pseudomonas aeur., Candida albicans and Clostridium spp. Hospital-acquired infections are significant problems in the world and especially in some Asian, Latin American, and African countries.
As a result of therapy using antibiotics in "a device for transferring information from the drug to the human body", this patient has eliminated all infectious agents and has felt healthy for the past 21 years. According to the conclusions of the surgeons observing the patient, the diagnosis of chronic sepsis was removed. The patient leads an active social life.
Therapy of chronic diseases includes, among other things, the treatment of diseases of the nervous system - neurodegenerative pathology, including multiple sclerosis, Alzheimer's disease and others, where the trigger of the process is a variety of bacterial and viral infections; the so-called autoimmune diseases - where the trigger of the process can also be an infection (the number of such diseases exceeds more than 150 names and represents a complex problem in terms of therapy for such patients, since, as a rule, such patients do not undergo therapy aimed at eliminating the pathogen), and many other diseases, the trigger of which can be also be various infections, etc.
Advantages of the proposed approach.
This method allows access to some regions of the human body that are difficult to access with traditional drugs, such as the lymphatic system, the brain, the spinal cord, the skeletal system, and the skin. The possibility of using the drug remotely without introducing the medicine into the human body ensures the absence of adverse drug effects and various allergic reactions and, most importantly, prevents the formation of resistance to different antimicrobial and antiviral drugs, a very urgent problem today. It significantly reduces the duration of therapy, not only because of its peculiarities but also because it is targeted: the organs and systems of the body are exposed separately.
The future of the proposed technology.
The proposed technology represents a unique approach to using well-known, proven drugs. It will eventually take its place in treating diseases of various internal organs.
References
1. Djumaeva N. A successful application of information technologies in treating multiple sclerosis: a case report. J Med Case Rep. 2024 Nov 25;18(1):561. doi: 10.1186/s13256-024-04909-1.